ADYX (Adynxx) Total Equity: $-11.06 Mil (As of Sep. 2019)


ADYX Adynxx Inc ADYX
16 GF Score
Price $0.00
View Full Analysis

What is Adynxx Total Equity?

Adynxx ADYX -99.00% 16 Total Equity is $-11.06 Mil as of Sep. 2019. GuruFocus rates ADYX with a GF Score™ of 16/100.

Adynxx's total equity for the quarter that ended in Sep. 2019 was $-11.06 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Adynxx Total Equity Historical Data

* Premium members only.

The historical data trend for Adynxx's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adynxx Total Equity Chart

Adynxx Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.51 52.43 32.09 15.67 8.25

Adynxx Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.54 8.25 7.39 -9.25 -11.06
ADYX
16GF Score
Adynxx Inc ADYX
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adynxx Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Adynxx's Total Equity for the fiscal year that ended in Dec. 2018 is calculated as

Total Equity=Total Assets(Q: Dec. 2018 )-Total Liabilities(Q: Dec. 2018 )
=9.679-1.427
=8.25

Adynxx's Total Equity for the quarter that ended in Sep. 2019 is calculated as

Total Equity=Total Assets(Q: Sep. 2019 )-Total Liabilities(Q: Sep. 2019 )
=3.254-14.316
=-11.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-11.06 Mil mean?
Adynxx (ADYX) has a Total Equity of $-11.06 Mil as of Sep. 2019. The total amount of equity as record on a company's balance sheet. View historical data for Adynxx and its competitors.
Is Adynxx's Total Equity too high?
Adynxx's current Total Equity is $-11.06 Mil. Overall, Adynxx has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Adynxx's Total Equity compare to TRPX and MITI?
Adynxx's Total Equity of $-11.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Adynxx and its competitors. Adynxx's current Total Equity is $-11.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adynxx stock overvalued right now?
Adynxx (ADYX) has a current Total Equity of $-11.06 Mil. The current Total Equity is $-11.06 Mil. Adynxx's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Adynxx (ADYX), the current Total Equity is $-11.06 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adynxx Business Description

Address 100 Pine Street, Suite 500, San Francisco, CA, USA, 94111
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.
16GF Score

Get the complete analysis for ADYX

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price